Partnered with:




VIDO-InterVac will continue Canada’s history of research into vaccines and infectious disease with a new CL3 facility.
Beating the Bugs
VIDO-InterVac will continue Canada's rich history of research into vaccines and infectious disease with a new CL3 facility opening in 2011

Vaccination has saved more lives than any other healthcare intervention. Its effectiveness and low cost have made it essential to maintaining public health.

WEB EXCLUSIVE
Research Summaries
Vaccines for the 21st Century

In the bioenergy, biofuels and industrial biotech sectors, demand exceeds supply.”
Is Job Growth Possible?
In the bioenergy, biofuels and industrial biotech sector, demand exceeds supply

Demand for biofuels products and services is expected to climb to 80 per cent nationally and 83 per cent globally over the next three to five years, according to a new report issued by BioTalent Canada.

WEB EXCLUSIVE
Generating Opportunity Report

Public-private partnerships fuel Dutch life sciences innovation and provide foreign biotechs with the ideal European gateway.
Public-private partnerships fuel Dutch life sciences innovation and provide foreign biotechs with the ideal European gateway

For Canadian companies looking to crack the greater European market, the Netherlands isn’t necessarily the first locale that comes to mind. But the Dutch life sciences community is working hard to change that, and with good reason.

WEB EXCLUSIVE
Extra Information






Bio Business is pleased to see the new decade in with the grand opening of our very own research store. Our research store provides vital access to a wealth of relevant, timely and robust intelligence from reliable, world-leading sources. Over 1,500 recent reports are available, tailored specifically towards biotech, pharma and healthcare industries – enabling you to make better strategic and operational decisions and continue to be commercially agile.

Visit today for our opening 30% discount offer!

Free IP Book!

Intellectual property, or IP, is probably more important to life sciences businesses than any other group. It’s imperative that Canadian biobusinesses learn about how to protect and profit from their ideas and innovations.


More Activity in 2010

Intralinks, a provider of information exchange solutions, announced the results of a survey of key decision-makers attending the BioNetwork West 2009 conference in California in October, on their anticipated deal activity in 2010 and the ways they expect to conduct them.


Jobs in Toronto

Toronto-based Vive Nano, an award-winning company that has developed an environmentally friendly process for creating products and materials using nanotechnology, will see an investment of almost $3.8 million through Ontario’s Innovation Demonstration Fund to help the company build a pilot plant, refine its processes and come to full production levels..